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Abstract
A study was undertaken to evaluate the hypoglycemic activity of polysaccharide extracted from Lycium 
barbarum (LBP). The various parameters studied included body weight (bw), fasting blood glucose levels (FBG), 
total cholesterol (TC) and triglyceride (TG) in diabetic and normal mice. LBP treatment (20, 40 mg/ kg body 
weight) for 28 days resulted in a significant decrease in the concentration of FBG, TC and TG in diabetes 
mellitus mice. Furthermore, LBP significantly increased body weight. The data demonstrated LBP at the dose of 
40 mg/kg bw exhibited the better effect. 
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Introduction
Diabetes mellitus is found in all parts of the world and is rapidly increasing in most parts of the world. As a
devastating disease, diabetes is affecting approximately 3% of the population worldwide (Skyler, 2004). For a 
long time, diabetics have been treated with several medicinal plants or their extracts based on the folklore 
medicine (Akhtar and Ali, 1984). Synthetic hypoglycemic agents can produce serious side effects and in addition, 
they are not suitable for use during pregnancy (Pari and Saravanan, 2002). Therefore, the search for more 
effective and safer hypoglycemic agents has continued to be an important area of active research. 
Lycium barbarum species are deciduous woody perennial plants, produce a bright orange-red, ellipsoid 
berry 1-2 cm long. The berries have been used in traditional Chinese medicine for about 1,900 years (Jin et al., 
2006). They have been used for the treatment of cerebral arteriosclerosis, liver or heart diseases, 
hypercholesterolemia and diabetes(Zhao and Liu, 2008). The active components of Lycium barbarum primarily 
contain water-soluble polysaccharides (Chen and Mu, 2007). They could be extracted with hot water followed by 
precipitation with ethanol to obtain high quantity of polysaccharides (Zhi et al., 2004; Gan et al., 2004; Zhang et 
al., 2004). LBP have been recently studied for their physiological and pharmaceutical activities. The purpose of 
this study was to investigate the hypoglycemic activity of LBP in alloxan-induced diabetic mice.
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Materials and Methods
Plant materials
Dried Lycium Barbarum (voucher No. 20080418) were purchased from a local drug market and the 
material was identified by Mr. king Li, a botanist of Qujing Normal University. A voucher specimen has been 
deposited in herbarium of Qujing Normal University.
Drugs and reagents
Alloxan was purchased from Sigma Co. (USA). Glucose Analyzer and strips were purchased from Roche 
Diagnostic Co. (USA). Reagents for total cholesterol (TC) and triglyceride (TG) were obtained from Beijing 
Chengxinde Biochemistry Reagent Company (Beijing, China). Reagents for serum insulin was purchased from 
Adlitteram Diagnostic Laboratories Co. (USA).
Extraction of LBP
Dried Lycium Barbarum was crushed in an electrical grinder and then powdered, 1000 g of this powder was 
immersed in tenfold dH2O, boiled at 100℃ for 12 hr (Ayiguli et al., 2007; Luo et al., 2000) and then the water 
extract was collected. The process was repeated once, and the extracts were combined and concentrated with a 
vacuum rotary evaporator at 70 ℃ (Luo et al., 2000; Gao et al., 2008; Liu et al., 2009 ). The concentrated 
solution was precipitated with addition of 4 times volume 95% ethanol and the precipitate was washed in turn 
with 100 % ethanol. 100 % Ether and acetone, polysaccharide extracted from Lycium barbarum was obtained by 
vacuum drying (Luo et al., 2000). The Unico-7200 spectrophotometer (Unico Co., Shanghai, China) was used to 
determine the content of polysaccharides in the above extracted product at 490 nm (Ayiguli et al., 2007; Wang et 
al., 2007). The calculated extraction yield of polysaccharides was 9.43%.
Experimental animals   
Male mice of original Kun-ming strain (18-22 g each) were used for the study. The study was carried out 
according to the “Principles of Laboratory Animal Care” (World Health Organization (WHO) Chronicle, 1985). 
A standard pellet diet and water were given ad libitum. The standard pellet diets consists of corn starch 50%, 
casein 21%, fish flour 10%, sucrose 8%, soybean oil 6.5%, vitamin mix 3%, mineral mix 1%, L-cystine 0.5%
(the Disease Control Center, Yunnan, China). Animals were maintained under a constant 12-hr light and dark 
cycle and an environmental temperature of 21-23 ℃ with relative air humidity of 45 % to 55 %.
Preparation of alloxan-induced diabetic mice
Diabetes was induced in fasted mice (12 hr) by intraperitoneal injection of 200 mg/kg bw of alloxan, 
freshly dissolved in sterile normal saline immediately at a concentration of 40 g/L (Shu et al., 2002; Wang et al., 
2004; Hu et al., 2006). Diabetes was confirmed by the determination of tail vein blood glucose levels on the third 
day after administration of alloxan. The mice with a blood glucose level above 11 mmol/L, as well as with 
polydipsia, polyuria, and polyphagia were selected for the experiment (Zhang et al., 2004; Yang et al., 2006 ).
Experimental Design 
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Forty Male mice were randomly divided into five equal groups as follows:
i) Normal control group(NC): normal control mice administered water daily for 28 days;
ii) Diabetic control group(DC): diabetic control mice administered water daily for 28 days; 
iii) Diabetic + LBP (20mg/kg) group(DLL): diabetic mice administered LBP (20mg/kg) daily for 28 days.;
  iv) Diabetic + LBP (40 mg/kg) group(DLH): diabetic mice administered LBP (40 mg/kg) daily for 28 days.; 
  v) Diabetic + glibenclamide (4 mg/kg) group(DG): diabetic mice administered reference drug glibenclamide 
(4 mg/kg) daily for 28 days (Chen and Huang, 2000; Zhang et al., 2002; Shan et al., 2005).
Animals of control group, NC and DC groups were subjected to forceful feeding of 0.5mL distilled 
water/100 g bw daily for 28 days to keep all the animals at same type of treatment condition in respect to BLP 
supplemented groups. 
During LBP and Glib supplement for 28 days, fasting blood glucose level was measured for once every 
week. Blood was collected from tip of the tail vein and fasting blood glucose level was measured by using a 
glucose analyzer. At the same time, the body weight of each mouse was measured. On 28th day of experiment, 
the mice were sacrificed by decapitation under light ether anesthesia and blood was collected from dorsal aorta 
and serum was separated by centrifugation for 5min and was kept at -20 ℃ for the biochemical assay of total 
cholesterol (TC), and triglyceride (TG). TC and TG were determined by enzyme methods. 
Acute toxicity studies
LBP was tested for its acute toxicity in male mice. The test was carried out by single oral administration of 
LBP at doses of 80, 240, 400 mg/kg to different groups of mice (5 mice in each group). The mortality and
general behavior was observed for one hr, four hr, and intermittently for next six hr, and again at 24 hr and 48 hr.
The parameters were observed are gross behavioral changes, grooming, alertness, sedation, loss of righting
reflex, tremors convulsions (Mukund et al., 2008).
Statistical analysis
All results were expressed as means ± SEM for each group. Data were analysed statistically by one-way
analysis of variance (ANOVA). The significance of the difference between the means of test and control studies 
was established by student’s t-test. P values of less than 0.05 were considered significant.
Results
Acute toxicity studies 
In the present study, toxicity test was carried up to high concentration of 400 mg/kg (10 times more than 
chosen dose). Even at this dose extract did not exhibit any sign of toxicity. Since the main purpose of this test is 
to get some idea on conspicuous behavioral changes and death, if any, and the LBP did not exhibit any toxic 
symptoms in the limited toxicity evaluation in male mice.
Effect of LBP on body weight 
The alloxan-induced diabetic mice exhibited loss of body weight. Before embarking on the experiment, all 
the groups had no significant difference in body weight (P >0.05) .A significant (P < 0.05) decrease in body 
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weight was detected in the DC, DLL and DLH groups as compared to the normal control group from 7 days after 
alloxan injection. However, the body weights in the DLH groups were significantly (P < 0.05) and 
dose-dependently increased as compared to those of the diabetic control from 14 days after administration,
which is comparable to that of the DG group. The results are shown in Figure1.
Effect of LBP on fasting blood glucose levels 
The alloxan-induced diabetic mice exhibited hyperglycemia. At the beginning, a significant (P< 0.05) 
increase in FBG was detected in the diabetic groups as compared to the normal control group. But these 
abnormal increases in blood glucose levels significantly (P < 0.05) and dose-dependently lowered in the LBP
-administered groups as compared to the diabetic control group from 7 days after administration. In the DG 
group, decrease was also significant (P < 0.05) from 7 days after administration. NC and DC groups did not 
show any significant variation on the blood glucose level throughout the experimental period (p > 0.05). The 
results are shown in Table 1.
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Figure 1: Effect of LBP on body weight (g) in mice
Effect of LBP on blood lipids levels
Diabetes mellitus is usually complicated with hyperlipoproteinemia. The present results showed that the TC 
and TG levels were significantly elevated in the diabetic control group as compared to the normal control group 
(P < 0.05). After supplementation with LBP, the alteration in lipid metabolism was partially attenuated as 
evidenced by decreased serum TG and TC levels in diabetic mice. The response was better in DLH group 
compared to the others group. The results are shown in Table 2.
Discussion
Diabetes mellitus is a serious chronic disease. Although oral anti-hyperglycemic agents and insulin are 
often successful in diabetes treatment, they have prominent side effects and fail to signiﬁcantly alter the course 
of diabetic complications. Effective control of the blood glucose level is a key step in preventing or reversing 
diabetic complications and improving the quality of life in both type 1 and type 2 diabetic patients (Chen et al., 
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2008). The present study shows that alloxan-induced diabetic mice presented obvious hyperglycemic symptoms, 
but LBP produces a significant antihyperglycemic effect when administered orally to alloxan-diabetic mice. The 
dosage of 40 mg/kg was more effective than that of 20 mg/kg.
Table 1: Effect of LBP on blood glucose Level (mmol/L )in mice
Days after dosing (day)Groups
0 7 14 21 28
NC 5.03±0.14 5.02±0.16 4.98±0.17 4.92±0.08 5.04±0.11
DC 15.24±0.39① 15.21±0.26① 15.21±0.35① 15.03±0.15① 15.12±0.29①
DLL 15.13±0.30① 9.43±0.21①② 8.41±0.21①② 7.45±0.15①② 6.79±0.16①②
DLH 15.28±0.28① 8.62±0.11①② 7.61±0.28①② 6.12±0.17①② 5.23±0.16①②
DG 15.17±0.29① 8.96±0.12①② 7.12±0.23①② 6.35±0.24①② 5.56±0.34①②
n=8; (mean±S.D., g); ①P < 0.05 as compared with normal control group.; ②P < 0.05 as compared with 
diabetic control Group
Table 2: Effect of LBP on blood lipids (mmol/L ) in mice
Groups TG TC
NC 1.58±0.03 2.64±0.04
DC 1.99±0.03① 3.28±0.05①
DLL 1.71±0.03①② 3.03±0.08①②
DLH 1.64±0.03①② 2.75±0.11①②
DG 1.66±0.0①② 2097±0.05①②
n=8; (mean±S.D., g);①P<0.05 as compared with normal control group; ②P < 0.05 as compared with 
diabetic control Group
Diabetes is also associated with hyperlipidemia. The serum TC and TG decreased significantly in diabetic
mice after LBP supplementation. These effects may be due to low activity of cholesterol biosynthesis enzymes 
and or low level of lipolysis which are under the control of insulin (Sharma et al., 2003). Lycium barbarum have 
been used to treat diabetes in folk tradition for a long time. From this study, we could conclude LBP possesses 
hypoglycemic effects and the dose of 40 mg/kg bw represents the optimal level for effecting a positive diabetic 
response in mice. Toxicity data have already proved that the LBP did not show any toxic reactions. So, it can be 
said that Lycium barbarum is a good natural material is a potential agent to treat diabetes, maybe the effective 
constituent is polysaccharide.
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